Gregory A Ewald MD

Cardiology•Saint Louis, MO

Heart Failure & Transplantation

Professor of Medicine, Interim Chief Cardiovascular Division, Washington University St Louis

Join to View Full Profile

4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-362-1291
Fax+1 314-454-8855

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1992 - 1997
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1989 - 1992
Northwestern University The Feinberg School of MedicineClass of 1989

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 1991 - 2026
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Fellow (FACC) American College of Cardiology

Clinical Trials

IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Start of enrollment: 2005 Jan 01
Completed
Not Applicable
A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Withdrawn
Phase 1
Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction Start of enrollment: 2007 Nov 01
Terminated
Phase 2
Decompensation Detection Study Start of enrollment: 2006 Mar 01
Completed
INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Terminated
Phase 3
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE Start of enrollment: 2015 Jul 01
Completed
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment Start of enrollment: 2012 Dec 01
Terminated
Not Applicable
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) Start of enrollment: 2013 Apr 01
Completed
Phase 2
Cardiovascular Improvements With MV ASV Therapy in Heart Failure Start of enrollment: 2013 Dec 01
Terminated
Not Applicable
Gas Exchange for Predicting Hospital Heart Failure Readmissions Start of enrollment: 2013 Oct 01
Unknown status
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
COMPLETED
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure Start of enrollment: 2014 Dec 30
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Javier Jimenez, Hanyu Ni, Stuart D Katz, Garrie J Haas, Jinwen Cao
Circulation. Genomic and Precision Medicine. 2025-03-28
Evaluation of Women with Peripartum or Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study.
Evan P Kransdorf, Rashmi Jain, Jonathan O Mead, Garrie Haas, Mark Hofmeyer
Medrxiv. 2025-02-21
Implementing Precision Medicine for Dilated Cardiomyopathy: Insights from The DCM Consortium.
Elizabeth Jordan, Hanyu Ni, Patricia Parker, Daniel D Kinnamon, Anjali Owens
Medrxiv. 2024-11-26

Journal Articles

Non‐Invasive Detection of Graft Injury After Heart Transplantation Using Donor‐Derived Cell‐Free DNA: A Prospective Multi‐Center Study
Gregory Ewald, Jon Kobashigawa, Kiran K Khush, Jignesh Patel, Eugene DePasquale, Sean Pinney, American journal of transplantation
Remote Monitoring of Patients with Heart Failure: A White Paper from the Heart Failure Society of America Scientific Statements Committee
Gregory A Ewald, Amanda R Vest, David J Whellan, Michael R Zile, Michael M Givertz, Journal of Cardiac Failure
Increased Prevalence of Cardiac Allograft Donors with Improved LV Systolic Function Utilizing an Out-of-Hospital Treatment and Recovery Center
Justin Hartupee, Shane Larue, Justin Vader, Gregory Ewald, Journal of Cardiac Failure

Lectures

Cardiology Update
Washington University School of Medicine, Saint Louis, Missouri - 6/9/2012

Authored Content

Remote Monitoring of Patients with Heart Failure: A White Paper from the Heart Failure Society of America Scientific Statements CommitteeOctober 2018
Increased Prevalence of Cardiac Allograft Donors with Improved LV Systolic Function Utilizing an Out-of-Hospital Treatment and Recovery CenterSeptember 2018

Press Mentions

Prabhu Named Cardiovascular Division DirectorJuly 16th, 2021

Grant Support

Action - A CHF Trial Investigating Outcomes Of ExerciseNational Heart, Lung, And Blood Institute2002–2006

Professional Memberships

American College of Cardiology - ACC
Member